Theranexus (EPA:ALTHX) | WebDisclosure

BRIEF

published on 09/29/2026 at 18:05, 1 month 12 days ago

THX Pharma Publishes its First Half 2026 Results

Half-year Results Batten-1 Rare Neurological Diseases THX Pharma Biocodex Agreement
BRIEF

published on 09/29/2026 at 18:05, 1 month 12 days ago

THX Pharma Releases Financial Results for H1 2026

Financial Results Revenue Growth Neurological Diseases THX Pharma Biocodex Partnership
BRIEF

published on 09/29/2026 at 18:05, 1 month 12 days ago

THX Pharma publie ses résultats financiers pour le premier semestre 2026

Résultats Financiers Croissance Des Revenus Maladies Neurologiques THX Pharma Partenariat Biocodex
PRESS RELEASE

published on 09/29/2026 at 18:00, 1 month 12 days ago

THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026
THX Pharma announces financial results for the six-month period ended June 30, 2026, showcasing revenue generation and strategic partnerships for rare neurological disease treatments

Financial Results Clinical-Stage Biopharmaceutical Batten-1 Rare Neurological Diseases THX Pharma
PRESS RELEASE

published on 09/29/2026 at 18:00, 1 month 12 days ago

THX PHARMA ANNONCE SES RESULTATS FINANCIERS DU PREMIER SEMESTRE 2026
THX Pharma publie ses résultats semestriels au 30 juin 2026, annonçant un chiffre d'affaires significatif, une trésorerie de 17,5M€ et des avancées dans les traitements des maladies neurologiques rares

Chiffre D'affaires Résultats Semestriels Trésorerie Maladies Neurologiques Rares THX Pharma
BRIEF

published on 09/09/2026 at 08:35, 2 months 2 days ago

Un Brevet Européen pour Batten-1 Renforce sa Protection

Batten-1 Maladie De Batten Brevet Européen Miglustat Protection
BRIEF

published on 09/09/2026 at 08:35, 2 months 2 days ago

European Patent Secures Batten-1's Future in Juvenile Batten Disease Treatment

Orphan Drug Designation Batten-1 Juvenile Batten Disease European Patent THX Pharma
BRIEF

published on 09/09/2026 at 08:35, 2 months 2 days ago

A European Patent for Batten-1 Strengthens its Protection

Batten-1 Batten Disease European Patent Miglustat Protection
BRIEF

published on 09/09/2026 at 08:35, 2 months 2 days ago

Un brevet européen garantit l'avenir du Batten-1 dans le traitement de la maladie de Batten juvénile.

Désignation De Médicament Orphelin Batten-1 Brevet Européen THX Pharma Maladie De Batten Juvénile
PRESS RELEASE

published on 09/09/2026 at 08:30, 2 months 2 days ago

Rectificatif : THX Pharma et la Beyond Batten Disease Foundation annoncent la délivrance d'un brevet européen protégeant l'utilisation de Batten-1 dans la maladie de Batten juvénile (CLN3)
THX Pharma et la Beyond Batten Disease Foundation annoncent la délivrance d'un brevet européen pour l'utilisation de Batten-1 dans la maladie de Batten juvénile (CLN3)

Batten-1 Maladie De Batten Brevet Européen THX Pharma Beyond Batten Disease Foundation

Published on 11/11/2026 at 19:31, 2 hours 48 minutes ago

Lion Copper Corp. Completes S-K 1300 Technical Report Summary for Bear Copper Deposit
Published on 11/11/2026 at 16:30, 5 hours 49 minutes ago

ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
Published on 11/11/2026 at 14:25, 7 hours 54 minutes ago

Route1 Announces 2026 Annual Meeting Results
Published on 11/11/2026 at 14:00, 8 hours 19 minutes ago

PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Published on 11/11/2026 at 14:00, 8 hours 19 minutes ago

NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers

View all ACCESSWIRE

Published on 11/11/2026 at 19:29, 2 hours 50 minutes ago

EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 3 hours 37 minutes ago

AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/11/2026 at 18:37, 3 hours 42 minutes ago

Holding(s) in Company
Published on 11/11/2026 at 18:36, 3 hours 43 minutes ago

Holding(s) in Company
Published on 11/11/2026 at 18:35, 3 hours 44 minutes ago

Holding(s) in Company

View all EQS

Published on 11/10/2026 at 18:00, 1 day 4 hours ago

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 1 day 4 hours ago

Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:40, 1 day 4 hours ago

Production du 3ième trimestre 2026
Published on 11/10/2026 at 17:35, 1 day 4 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 1 day 4 hours ago

CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.

View all LES ECHOS COMFI WIRE

News